Letters to the Editor

The novel L-nucleoside analogue, 5-Fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia

Princess Margaret Cancer Center, University Health Network, Ontario, Canada;
Princess Margaret Cancer Center, University Health Network, Ontario, Canada;
Medivir AB,Huddinge, Sweden;
Medivir AB, Huddinge, Sweden
Medivir AB, Huddinge, Sweden
Medivir AB, Huddinge, Sweden
Medivir AB, Huddinge, Sweden
Medivir AB, Huddinge, Sweden
Medivir AB, Huddinge, Sweden
Medivir AB, Huddinge, Sweden
Medivir AB, Huddinge, Sweden
Medivir AB, Huddinge, Sweden
Princess Margaret Cancer Center, University Health Network, Ontario, Canada;
Princess Margaret Cancer Center, University Health Network, Ontario, Canada;
Princess Margaret Cancer Center, University Health Network, Ontario, Canada;
Princess Margaret Cancer Center, University Health Network, Ontario, Canada;
Princess Margaret Cancer Center, University Health Network, Ontario, Canada;
Princess Margaret Cancer Center, University Health Network, Ontario, Canada;
Medivir AB, Huddinge, Sweden
Princess Margaret Cancer Center, University Health Network, Ontario, Canada;
Medivir AB, Huddinge, Sweden
Haematologica Early view Dec 19, 2019 https://doi.org/10.3324/haematol.2019.226795